Edition: India  
 
> >

Teva Pharm to market medical cannabis inhaler in Israel

Reuters India Monday, 28 November 2016
JERUSALEM (Reuters) - Israel's Teva Pharmaceuticals has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

You Might Like


Other recent news in Health

Nation Marks Roe v Wade Anniversary in PRESIDENT Trump EraFormer President JIMMY CARTER Urges Support for Trump Administration
TRUMP ORDER paves way for agencies to weaken health lawTrump, Pence Attend National PRAYER SERVICE Stressing Reconciliation
Quake Strikes Near PAPUA NEW GUINEA; Tsunami PossibleGermany's Schaeuble Tells Britain to Look to Swiss for BREXIT Ideas

Twitter

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2017 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter